Skip to main content
Clinical Trials/NCT07419438
NCT07419438
Recruiting
Not Applicable

Supraglottic Airway Interface for Positive Pressure Ventilation During Delivery Room Resuscitation of Premature Infants: A Pilot Feasibility Trial

University of Pennsylvania1 site in 1 country20 target enrollmentStarted: March 13, 2026Last updated:
InterventionsSupraglottic Airway

Overview

Phase
Not Applicable
Status
Recruiting
Enrollment
20
Locations
1
Primary Endpoint
Feasibility of Supraglottic Airway as Primary Ventilation Interface

Overview

Brief Summary

The goal of this single-arm intervention trial is to learn whether using a supraglottic airway (SA) as the primary interface for positive pressure ventilation (PPV) is feasible during delivery room resuscitation of premature infants. This study will be conducted in premature infants born between 29 0/7 and 33 6/7 weeks' gestation who require PPV at birth.

The main question it aims to answer is: Is it feasible to use a supraglottic airway as the primary interface to provide effective PPV during delivery room resuscitation in 29 0/7 to 33 6/7 weeks' gestation premature infants?

Participants will (1)Be screened prenatally and have informed consent obtained from the birth parent prior to delivery; (2)Be rescreened for eligibility on the day of delivery before receiving the study intervention; (3)Receive PPV using a supraglottic airway as the primary ventilation interface if resuscitation is required at birth; and (4)Have clinical and procedural data collected during delivery room resuscitation and for up to 24 hours after birth.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
0 Days to 1 Day (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Gestational age 29 0/7 to 33 6/7 weeks at birth
  • Estimated fetal weight \>/= 1000 grams at birth
  • Clinical decision to initiate PPV
  • Parental informed consent

Exclusion Criteria

  • Major anomalies or aneuploidy
  • Palliative care planned or considered
  • Not resuscitated in the infant resuscitation room

Arms & Interventions

Supraglottic Airway

Experimental

Premature infants who require positive pressure ventilation immediately after birth will receive ventilation through a supraglottic airway used as the primary airway interface during delivery room resuscitation.

Intervention: Supraglottic Airway (Other)

Outcomes

Primary Outcomes

Feasibility of Supraglottic Airway as Primary Ventilation Interface

Time Frame: Immediately after birth (up to 10 minutes of life)

Feasibility defined as successful use of a supraglottic airway as the primary interface to deliver positive pressure ventilation for up to 10 minutes of life or until discontinuation of positive pressure ventilation, without need for immediate escalation to an alternative airway interface.

Secondary Outcomes

  • Time to Supraglottic Airway Placement During Resuscitation(Immediately after birth)
  • Duration of Supraglottic Airway Use During Resuscitation(Immediately after birth)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials